CAR T CELL THERAPY
Clinical trials for CAR T CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough leukemia in early trial
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy (FO33 CAR-T) for people with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target the CD33 protein found on most AML…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New CAR-T therapy made inside the body could cut costs for blood cancer patients
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy that is made inside the body, avoiding the expensive and complex lab process normally needed. It targets two proteins (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell acute leukemia or …
Matched conditions: CAR T CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Blood cancer patients' quality of life under the microscope: stem cell vs. CAR-T therapy compared.
Knowledge-focused Not yet recruitingThis study follows 162 blood cancer patients to see how their quality of life and symptoms change during a hospital stay for either a stem cell transplant or CAR-T therapy. Patients fill out a simple questionnaire at several points from admission to discharge. The goal is to unde…
Matched conditions: CAR T CELL THERAPY
Sponsor: Associazione Qol-one • Aim: Knowledge-focused
Last updated May 26, 2026 06:11 UTC
-
Gene therapy patients monitored for 15 years in safety study
Knowledge-focused Not yet recruitingThis study follows 500 people who have received or will receive gene therapy products from Seattle Children's Therapeutics. The goal is to track long-term safety and any delayed side effects over up to 15 years. Participants will have regular check-ups and lab tests, but no new t…
Matched conditions: CAR T CELL THERAPY
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:01 UTC
-
New study probes hidden brain risks of CAR-T cancer treatment
Knowledge-focused Not yet recruitingThis study looks at why some people getting CAR-T therapy for cancer develop serious brain side effects called ICANS. Researchers will use brain scans and thinking tests to compare those who get severe ICANS with those who don't. The goal is to understand the link between brain i…
Matched conditions: CAR T CELL THERAPY
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Can the RSV vaccine protect vulnerable cancer survivors?
Knowledge-focused Not yet recruitingThis study looks at whether the RSV vaccine (Abrysvo) can help people with blood cancers who have had a bone marrow transplant or CAR-T cell therapy build immunity against RSV. About 30 adults will get the vaccine, and researchers will measure their antibody levels before and aft…
Matched conditions: CAR T CELL THERAPY
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC